Ischemia Technologies - About the company
Ischemia Technologies is a deadpooled company based in Waltham (United States), founded in 1997. It operates as a Develops, manufactures, and markets in vitro diagnostic tests for cardiac ischemia. Ischemia Technologies has raised $12.7M in funding. The company has 29 active competitors, including 7 funded and 5 that have exited. Its top competitors include companies like Conavi, Ionetix and Acarix.
Company Details
Ischemia Technologies develops, manufactures, and markets in vitro diagnostic tests for cardiac ischemia. It focuses on cardiovascular and acute care medicine.
Key Metrics
Founded Year
1997
Location
Waltham, United States
Stage
Deadpooled
Total Funding
$12.7M in 3 rounds
Latest Funding Round
Investors
Ranked
9th among 29 active competitors
Employee Count
11 - 50 as on Jul 01, 2024
Sign up to download Ischemia Technologies' company profile
Ischemia Technologies's funding and investors
Ischemia Technologies has raised a total funding of $12.7M over 3 rounds. Its first funding round was on Dec 21, 2000. Its latest funding round was a Series C round on Mar 2003 for $*****. 1 investor participated in its latest round. Ischemia Technologies has 5 institutional investors.
Here is the list of recent funding rounds of Ischemia Technologies:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 2003 | 4571018 | Series C | 8561716 | 2536812 | 6894195 | 9895032 |
Jul 12, 2001 | 1028827 | Series C | 6085478 | 3084585 | 4728440 | |
Dec 21, 2000 | 4370680 | Series B | 5141373 | 8921056 | 2287125 | 9865281 |
Access funding benchmarks and valuations. Sign up today!View details of Ischemia Technologies's funding rounds and investors
Ischemia Technologies' founders and board of directors
Founder? Claim ProfileIschemia Technologies' employee count trend
Ischemia Technologies has 11 - 50 employees as of Jul 24. Here is Ischemia Technologies's employee count trend over the years:
Uncover Ischemia Technologies' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Ischemia Technologies's Competitors and alternates
Top competitors of Ischemia Technologies include Conavi, Ionetix and Acarix. Here is the list of Top 10 competitors of Ischemia Technologies, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | A catheter-based ultrasound system for cardiac imaging | $27.7M | 66/100 | ||
2nd |  Ionetix 2009, San Francisco (United States), Series C | Radiopharmaceutical solutions provider specializing in cyclotron technology and targeted alpha therapy | $61.1M | 56/100 | |
3rd | Provider of a screening device for acoustic coronary artery diseases | $9.97M | 53/100 | ||
4th | Infraredx 1998, Burlington (United States), Acquired | Intravascular imaging pioneers improving coronary artery disease treatment and patient outcomes | $101M | 48/100 | |
5th | Cleveland HeartLab 2008, Cleveland (United States), Acquired | Innovative cardiovascular biomarker testing for risk identification and disease prevention | $38.9M | 47/100 | |
6th | GlyCardial Diagnostics 2017, Barcelona (Spain), Series A | In vitro diagnostic for myocardial ischemia | $2.8M | 37/100 | |
7th |  Kaminari Medical 2018, Rotterdam (Netherlands), Series A | Developer of diagnostic solution for vulnerable plaque in the coronary arteries | $4.16M | 35/100 | |
8th | AUM Cardio 2009, Northfield (United States), Series B | Device to detect coronary artery blockage | $11.1M | - | 35/100 |
9th | Ischemia Technologies 1997, Waltham (United States), Deadpooled | Develops, manufactures, and markets in vitro diagnostic tests for cardiac ischemia | $12.7M | 31/100 | |
10th | POINT Biomedical 1996, San Carlos (United States), Deadpooled | Domain name pointbio.com is for sale via Sedo Domain Parking | $56.4M | 31/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Ischemia Technologies's competitors? Click here to see the top ones
Ischemia Technologies's Investments and acquisitions
Ischemia Technologies has made no investments or acquisitions yet.
News related to Ischemia Technologies
•
IMA Agrees to Acquire Ischemia TechnologiesStreetInsider.com•Feb 16, 2005•Inverness Medical Innovations, Ischemia Technologies
•
Ischemia Technologies Closes on $8.4 Million in Series D FinancingBusiness Wire•Mar 27, 2003•Ischemia Technologies
•
Ischemia Technologies Names James Weersing as Chairman.MILLER/SHANDWICK TECHNOLOGIES, INC.•Nov 22, 2002•Ischemia Technologies
•
Ischemia Technologies raises $10.3mm in Series B financingInforma•Nov 08, 2000•Ischemia Technologies
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Ischemia Technologies
Explore our recently published companies
- Intute - India based, Unfunded company
- Belong - New York City based, 2024 founded, Unfunded company
- Pimetric - 2025 founded, Unfunded company
- YAMAHA MOTOR FINANCE CORPORATION - Cypress based, 1987 founded, Unfunded company
- UPTOWN - Oakland based, 2009 founded, Unfunded company
- PBI Performance Products - Charlotte based, 1969 founded, Unfunded company
